drugset / Trial / NCT02231242

Intrathecal Stem Cells for Cerebral Palsy Phase II

NCT02231242

Phase 2 Unknown 60 enrolled Hospital Universitario Dr. Jose E. Gonzalez
RandomizedCrossoverSingle-blindSupportive care

Summary

The purpose of this study is to determine whether the infusion of intrathecal autologous bone marrow total nucleated cells would improve the neurologic evolution of pediatric patients with quadriparetic cerebral palsy.

Timeline

Start
2013-09
Primary completion
2015-12
Completion
2016-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject bone marrow total nucleated cells Cell therapy 10 ml Intrathecal
Background Granulocyte colony-stimulating factor Protein / enzyme biologic 10 ug/kg Subcutaneous

Indications